List of Figures
Figure 1: Respiratory Complications Therapeutics Market, Global, Epidemiology Patterns for Pneumonia Incidence, 2015–2022 17
Figure 2: Respiratory Complications Therapeutics Market, Global, Epidemiology Patterns for Pneumococcal Vaccinations (million), 2015–2022 18
Figure 3: Respiratory Complications Therapeutics Market, Global, Epidemiology Patterns for PAH, 2015–2022 19
Figure 4: Respiratory Complications Therapeutics Market, Global, Epidemiology Patterns for Tuberculosis, 2015–2022 19
Figure 5: Respiratory Complications Therapeutics Market, Global, Prevnar 13 Revenue Forecast, 2015–2022 31
Figure 6: Respiratory Complications Therapeutics Market, Global, Synflorix Revenue Forecast, 2015–2022 32
Figure 7: Respiratory Complications Therapeutics Market, Global, Uptravi Revenue Forecast, 2016–2022 33
Figure 8: Respiratory Complications Therapeutics Market, Global, Opsumit Revenue Forecast, 2015–2022 34
Figure 9: Respiratory Complications Therapeutics Market, Global, Eliquis Revenue Forecast, 2015–2022 35
Figure 10: Respiratory Complications Therapeutics Market, Global, Xarelto Revenue Forecast, 2015–2022 37
Figure 11: Respiratory Complications Therapeutics Market, Global, Synagis Revenue Forecast, 2015–2022 38
Figure 12: Respiratory Complications Therapeutics Market, Global, Ventolin Revenue Forecast, 2015–2022 39
Figure 13: Respiratory Complications Therapeutics Market, Global, Infanrix Revenue Forecast, 2015–2022 40
Figure 14: Respiratory Complications Therapeutics Market, Global, Boostrix Revenue Forecast, 2015–2022 41
Figure 15: Respiratory Complications Therapeutics Market, Global, Pipeline by Stage of Development, Molecule Type and Program Type, 2017 43
Figure 16: Respiratory Complications Therapeutics Market, Global, Pipeline for Key Indications by Stage of Development, 2017 44
Figure 17: Respiratory Complications Therapeutics Market, Global, Pipeline for Key Indications by Molecule Type, 2017 45
Figure 18: Respiratory Complications Therapeutics Market, Global, Pipeline by Molecular Target, 2017 47
Figure 19: Respiratory Complications Therapeutics Market, Global, Pipeline for Key Indications by Molecular Target, 2017 48
Figure 20: Respiratory Complications Therapeutics Market, Global, Clinical Trial Attrition Rates by Stage of Development (%), 2006–2017 49
Figure 21: Respiratory Complications Therapeutics Market, Global, Clinical Trial Attrition Rates by Stage of Development and Indication (%), 2006–2017 50
Figure 22: Respiratory Complications Therapeutics Market, Global, Clinical Trial Attrition Rates by Stage of Development and Molecule Type (%), 2006–2017 51
Figure 23: Respiratory Complications Therapeutics Market, Global, Clinical Trial Attrition Rates by Stage of Development and Molecular Target (%), 2006–2017 52
Figure 24: Respiratory Complications Therapeutics Market, Global, Clinical Trial Duration by Stage of Development (months), 2006–2017 53
Figure 25: Respiratory Complications Therapeutics Market, Global, Clinical Trial Duration by Stage of Development and Indication (months), 2006–2017 54
Figure 26: Respiratory Complications Therapeutics Market, Global, Clinical Trial Duration by Stage of Development and Molecule Type (months), 2006–2017 55
Figure 27: Respiratory Complications Therapeutics Market, Global, Clinical Trial Duration by Stage of Development and Molecular Target (months), 2006–2017 56
Figure 28: Respiratory Complications Therapeutics Market, Global, Clinical Trial Size by Stage of Development (participants), 2006–2017 56
Figure 29: Respiratory Complications Therapeutics Market, Global, Clinical Trial Size by Stage of Development and Indication (participants), 2006–2017 57
Figure 30: Respiratory Complications Therapeutics Market, Global, Clinical Trial Size by Stage of Development and Molecule Type (participants), 2006–2017 58
Figure 31: Respiratory Complications Therapeutics Market, Global, Clinical Trial Size by Stage of Development and Molecular Target (participants), 2006–2017 59
Figure 32: Respiratory Complications Therapeutics Market, Global, Clinical Program Size by Stage of Development (participants), 2006–2017 60
Figure 33: Respiratory Complications Therapeutics Market, Global, Clinical Program Size by Stage of Development and Indication (participants), 2006???2017 60
Figure 34: Respiratory Complications Therapeutics Market, Global, Clinical Program Size by Stage of Development and Molecule Type (participants), 2006–2017 61
Figure 35: Respiratory Complications Therapeutics Market, Global, Clinical Program Size by Stage of Development and Molecular Target (participants), 2006–2017 62
Figure 36: Respiratory Complications Therapeutics Market, Global, Revenue Forecast for Solithera ($m), 2017–2022 64
Figure 37: Respiratory Complications Therapeutics Market, Global, Revenue Forecast for Carbavance ($m), 2017–2022 65
Figure 38: Respiratory Complications Therapeutics Market, Global, Revenue for Respiratory Syncytial Virus Vaccine ($m), 2018–2022 66
Figure 39: Respiratory Complications Therapeutics Market, Global, Market Size ($bn), 2015–2022 68
Figure 40: Respiratory Complications Therapeutics Market, Global, Annual Revenue by Generic Products ($m), 2015–2022 70
Figure 41: Respiratory Complications Therapeutics Market, Global, Annual Revenue Forecast for Vaccines ($bn), 2015–2022 71
Figure 42: Respiratory Complications Therapeutics Market, Global, Annual Revenue Forecast for Drugs Targeting G-Protein Coupled Receptors ($bn), 2015–2022 71
Figure 43: Respiratory Complications Therapeutics Market, Global, Annual Revenue Forecast for Drugs Targeting Enzymes ($bn), 2015–2022 72
Figure 44: Respiratory Complications Therapeutics Market, Global, Annual Revenue Forecast for Drugs with Bacterial/Viral Targets ($bn), 2015–2022 73
Figure 45: Respiratory Complications Therapeutics Market, Global, Company Analysis Matrix, 2015–2022 74
Figure 46: Respiratory Complications Therapeutics Market, Global, Forecast Market Share by Company (%), 2015–2022 76
Figure 47: Respiratory Complications Therapeutics Market, Global, Companies by Compound Annual Growth Rate (%), Base Year–2022 77
Figure 48: Respiratory Complications Therapeutics Market, Global, Pfizer Annual Revenue Forecast ($bn), 2015–2022 78
Figure 49: Respiratory Complications Therapeutics Market, Global, Actelion Annual Revenue ($bn), 2015–2022 79
Figure 50: Respiratory Complications Therapeutics Market, Global, GSK Annual Revenue ($bn), 2015–2022 80
Figure 51: Respiratory Complications Therapeutics Market, Global, Bayer Annual Revenue ($bn), 2015–2022 81
Figure 52: Respiratory Complications Therapeutics Market, Global, Bristol-Myers Squibb Annual Revenue ($bn), 2015–2022 82
Figure 53: Respiratory Complications Therapeutics Market, Global, Novavax Annual Revenue ($m), 2018–2022 83
Figure 54: Respiratory Complications Therapeutics Market, Global, United Therapeutics Annual Revenue ($bn), 2015–2022 84
Figure 55: Respiratory Complications Therapeutics Market, Global, Cluster by Growth and Market Share, 2015–2022 85
Figure 56: Respiratory Complications Therapeutics Market, Global, Companies by Type, 2017 86
Figure 57: Respiratory Complications Therapeutics Market, Global, High-Activity and Late-Stage Developers by Level of Specialization, 2017 87
Figure 58: Respiratory Complications Therapeutics Market, Global, Proportion of Total Company Revenue Attributed to Respiratory Complications, 2015–2022 88